Animal models for inherited peripheral neuropathies: Chances to find treatment strategies?

Journal of Neuroscience Research

Volumn 61, Issue 3, 2000, Pages 244-250

  Martini, Rudolf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Animal models; Inherited peripheral neuropathies; Myelin; Schwann cell

Indexed keywords

GAP JUNCTION PROTEIN; MYELIN; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEMYELINATING NEUROPATHY; GENE MUTATION; GENE THERAPY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; KNOCKOUT MOUSE; MOUSE; MYELINATION; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PATHOGENESIS; PERIPHERAL NEUROPATHY; POINT MUTATION; PRIORITY JOURNAL; RAT; SCHWANN CELL; T LYMPHOCYTE;

EID: 0034254710     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20000801)61:3<244::aid-jnr2>3.0.co;2-r     Document Type: Article

References (68)

1. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease
2. Hypermyelination and demyelinating peripheral neuropathy in pmp22-deficient mice
3. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy
4. Late onset neurodegeneration in mice with increased dosage of the proteolipid protein gene
5. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32
6. Functional gap junctions in the Schwann cell myelin sheath
7. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: Clinical and electrophysiologic study
8. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype
9. Altered trafficking of mutant connexin32
10. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
11. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22
12. Peripheral myelin protein 22 and protein zero: A novel association in peripheral nervous system myelin
13. Prednisolone-responsive hereditary motor and sensory neuropathy
14. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice
15. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease
16. Disruption of the P0 gene in mice leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons
17. Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination
18. Transgenic and natural mouse models of proteolipid protein (PLP)-related dysmyelination and demyelination
19. Effective gene transfer of lacZ and P0 into Schwann cells of P0-deficient mice
20. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors
21. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy
22. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA
23. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice
24. Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage
25. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene
26. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene
27. Inherited neuropathies: From gene to disease
28. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage
29. Animal models for inherited peripheral neuropathies
30. Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules
31. P0-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies
32. Inherited demyelinating neuropathies: From gene to disease
33. RAG-1-deficient mice have no mature B and T lymphocytes
34. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: New facts and hypotheses
35. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies
36. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies
37. Molecular genetics and biology of inherited peripheral neuropathies: A fast-moving field
38. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice
39. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease
40. Charcot-Marie-Tooth disease and related neuropathies: Molecular basis for distinction and diagnosis
41. Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells
42. Distal axonopathy in peripheral nerves of PMP22 mutant mice
43. Charcot-Marie-Tooth disease: Histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1)
44. Molecular basis of inherited neuropathies
45. Molecular genetics of demyelination: New wrinkles on an old membrane
46. Connexin32-null mice develop demyelinating peripheral neuropathy
47. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease
48. Peripheral nerves of a mouse model for Charcot-Marie-Tooth neuropathy 1B show infiltration of macrophages and CD4- and CD8-positive lymphocytes
49. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance
50. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain
51. X-linked dominant Charcot-Marie-Tooth neuropathy: Clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations
52. A transgenic rat model of Charcot-Marie-Tooth disease
53. HMSN III phenotype due to homozygous expression of a dominant HMSN II gene
54. Heterozygous P0 knock-out mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy
55. Biology and genetics of hereditary motor and sensory neuropathies
56. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype
57. Krox-20 controls myelination in the peripheral nervous system
58. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A
59. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth 1B, Dejerine-Sottas, and congenital hypomyelination
60. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies
61. Hereditary peripheral neuropathies: Clinical forms, genetics, and molecular mechanisms
62. Mouse models of myelin diseases
63. Dominant-negative effect on adhesion by myelin P0 protein truncated in its cytoplasmic domain
64. 0 overexpression causes congenital hypomyelination of peripheral nerves
65. Schwann cell myelination requires timely and precise targeting of P0 protein
66. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction
67. Myelin Po protein mutated at Cys21 has a dominant-negative effect on adhesion of wild type P0